Literature DB >> 18424356

Cognitive and motor components of response speed in the stroop test in Parkinson's disease patients.

Yi-Hsing Hsieh1, Kuan-Jen Chen, Chin-Chi Wang, Chiou-Lian Lai.   

Abstract

This study assessed the performance of patients with Parkinson's disease (PD) in the Stroop test. Twenty-seven patients with PD (17 men, 10 women; mean age, 63.3 +/- 10.5 years) and 27 age-matched controls (14 men, 13 women; mean age, 63.5 +/- 9.2 years) were administered the color-naming, word-reading, and incongruent color-word-naming tasks in the Stroop test. Compared with the normal control group, the PD group had slower speeds for all three tasks and greater Stroop interference, indicating a response inhibition deficit in PD patients. Further analysis indicated that slowness during color naming might be due to motor slowness, rather than a central cognitive processing problem in color discrimination. In conclusion, the performance of the PD group on the three tasks of the Stroop test suggests that the PD patients were deficient in motor responses and cognitive inhibitory abilities.

Entities:  

Mesh:

Year:  2008        PMID: 18424356     DOI: 10.1016/S1607-551X(08)70117-7

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  13 in total

1.  Stroop test performance in impulsive and non impulsive patients with Parkinson's disease.

Authors:  Atbin Djamshidian; Sean S O'Sullivan; Andrew Lees; Bruno B Averbeck
Journal:  Parkinsonism Relat Disord       Date:  2011-01-17       Impact factor: 4.891

2.  Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.

Authors:  Avner Thaler; Anat Mirelman; Tanya Gurevich; Ely Simon; Avi Orr-Urtreger; Karen Marder; Susan Bressman; Nir Giladi
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

3.  Parkinson's disease and the Stroop color word test: processing speed and interference algorithms.

Authors:  Shannon M Sisco; Elizabeth Slonena; Michael S Okun; Dawn Bowers; Catherine C Price
Journal:  Clin Neuropsychol       Date:  2016-06-06       Impact factor: 3.535

4.  The sensitivity and specificity of cognitive screening instruments to detect cognitive impairment in older adults with severe psychiatric illness.

Authors:  R Scott Mackin; Liat Ayalon; Leilani Feliciano; Patricia A Areán
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-01-25       Impact factor: 2.680

5.  Neural Mechanisms of Selective Attention in Children with Amblyopia.

Authors:  Aibao Zhou; Yanfei Jiang; Jianming Chen; Jianlan Wei; Baobao Dang; Shifeng Li; Qiongying Xu
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

6.  Fibromyalgia patients had normal distraction related pain inhibition but cognitive impairment reflected in caudate nucleus and hippocampus during the Stroop Color Word Test.

Authors:  Sofia Martinsen; Pär Flodin; Jonathan Berrebi; Monika Löfgren; Indre Bileviciute-Ljungar; Martin Ingvar; Peter Fransson; Eva Kosek
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 7.  Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effects.

Authors:  Peter Manza; Matthew Amandola; Vivekanand Tatineni; Chiang-Shan R Li; Hoi-Chung Leung
Journal:  NPJ Parkinsons Dis       Date:  2017-07-07

Review 8.  The Stroop Color and Word Test.

Authors:  Federica Scarpina; Sofia Tagini
Journal:  Front Psychol       Date:  2017-04-12

9.  Quantitative electromyographic analysis of reaction time to external auditory stimuli in drug-naïve Parkinson's disease.

Authors:  Do-Young Kwon; Byung Kyu Park; Ji Won Kim; Gwang-Moon Eom; Junghwa Hong; Seong-Beom Koh; Kun-Woo Park
Journal:  Parkinsons Dis       Date:  2014-03-02

10.  Concurrent exergaming and transcranial direct current stimulation to improve balance in people with Parkinson's disease: study protocol for a randomised controlled trial.

Authors:  Dale M Harris; Timo Rantalainen; Makii Muthalib; Liam Johnson; Rachel L Duckham; Stuart T Smith; Robin M Daly; Wei-Peng Teo
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.